title: Conservative treatment of cervical pregnancy by curettage and local prostaglandin injection.
abstract: Recently, various conservative regimens for the treatment of cervical pregnancy have been introduced to preserve fertility in young women, with methotrexate being one of the most widely used drugs. The success of conservative treatment depends on early preoperative diagnosis. We report three cases of first trimester cervical pregnancy, successfully treated by curettage to evacuate the conceptus, followed by local prostaglandin instillation to prevent severe haemorrhage. In one patient, intra-amniotic instillation of hyperosmolar glucose was necessary to terminate fetal cardiac activity. beta-Human chorionic gonadotrophin returned to normal within 3 weeks in one patient and within 7 weeks in another, both of whom became pregnant again within 1 year, resulting in term deliveries. The third patient was lost to follow-up after 1 week. The advantage of prostaglandin and curettage is the absence of major side-effects to the mother or the fetus of a subsequent pregnancy. The management strategies used in the treatment of cervical pregnancies and the results obtained since the introduction of methotrexate in 1989 are discussed in the context of previously published literature. The incidence of subsequent pregnancies among women treated medically versus women treated surgically is reported.
authors.affiliation: Department of Gynaecology and Obstetrics, Landeskrankenanstalten Salzburg, Austria.
authors.forename: D
authors.initials: D
authors.lastname: Spitzer
authors.forename: H
authors.initials: H
authors.lastname: Steiner
authors.forename: A
authors.initials: A
authors.lastname: Graf
authors.forename: M
authors.initials: M
authors.lastname: Zajc
authors.forename: A
authors.initials: A
authors.lastname: Staudach
mesh_terms: D000328:Adult; D002584:Cervix Uteri; D003131:Combined Modality Therapy; D004107:Dilatation and Curettage; D005260:Female; D006801:Humans; D007267:Injections; D008727:Methotrexate / Q000627:therapeutic use; D006473:Postpartum Hemorrhage / Q000517:prevention & control; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000628:therapy*; D011453:Prostaglandins / Q000627:therapeutic use*
chemical_list: D011453:Prostaglandins; D008727:Methotrexate